metformin hydrochloride; canagliflozin
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (metformin hydrochloride; canagliflozin) by Macleods Pharms is sglt2, expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Approved for established cardiovascular disease ( ), nonfatal myocardial infarction, nonfatal stroke) in adults with type 2 diabetes mellitus and 6 more indications.
Drug data last refreshed 14h ago
SGLT2, expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Canagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, canagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for…
Worked on CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE at Macleods Pharms? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes